Anika Therapeutics | Aktuelle Verpflichtungen

Aktienkurs
10.33
Täglich Wechseln
0.10 0.98%
Monatlich
9.78%
Jährlich
-41.84%
Q1 Prognose
25.10




Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 14.58B 1.14B 2025-09
Agenus USD 287.13M 52.57M 2025-09
Agios Pharmaceuticals USD 74.76M 4.35M 2025-09
Anika Therapeutics USD 19.09M 3.01M 2025-09
Arrowhead Research USD 347.42M 151.94M 2025-12
Enanta Pharmaceuticals USD 48.56M 4.01M 2025-09
Halozyme Therapeutics USD 837.23M 702.95M 2025-09
Heron Therapeutics USD 89.71M 168.89M 2025-09
Insmed USD 417.21M 105.53M 2025-09
Integra LifeSciences USD 364.05M 565.75M 2025-09
Intrexon USD 23.02M 38K 2024-06
J&J USD 50.87B 3.31B 2025-09
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Ligand Pharmaceuticals USD 30.54M 34.2M 2025-09
MacroGenics USD 44.47M 5.47M 2025-09
Merit Medical Systems USD 230.48M 4.9M 2025-09
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 3.76B 2025-12
Smith & Nephew USD 1.54B 236M 2025-12
Stryker USD 7.79B 380M 2025-12
Surmodics USD 20.54M 347K 2024-09
Veracyte USD 72.15M 4.28M 2025-09
Xencor USD 86.48M 9.6M 2025-09
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12


Anika Therapeutics Aktuelle Verpflichtungen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.